Sign Up
Stories
Genetic Technologies Closes Funding Round
Share
Addex Therapeutics Meeting
Addex Therapeutics to Participate in Bio...
Addex Therapeutics: Financial Updates an...
Abaxx Technologies Inc. Updates
Addex Therapeutics Enters ADS Offering A...
Adex Mining Secures $1M Loan
Overview
API
Genetic Technologies Limited finalizes a US$2 million registered offering of American Depositary Shares (ADSs) at US$2.00 per ADS and issues unregistered warrants for additional ADSs in a private placement.
Ask a question
How does this funding round position Genetic Technologies in the genomics market landscape?
How will the secured funds impact Genetic Technologies' research and development efforts?
What potential strategic initiatives might Genetic Technologies pursue with the additional capital?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage